Examines reasons for triptan discontinuation in migraine patients using rimegepant, suggesting critical patient insights.
Understand the reasons for triptan discontinuation in people using rimegepant for the acute treatment of migraine.
No takes yet. Share an insight, caveat, or question.
Blakeman et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: